A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for.

Slides:

Advertisements

Similar presentations

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Advertisements

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

Lobar lung transplantation: One size fits all

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Victor van Berkel, MD, PhD

The Journal of Thoracic and Cardiovascular Surgery

How should we treat air leaks?

Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial Stacey.

Go on-pump or off-pump in diabetic patients?

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

Should lung transplantation be performed using donation after cardiac death? The United States experience David P. Mason, MD, Lucy Thuita, MS, Joan M.

Bigger The Journal of Thoracic and Cardiovascular Surgery

Propensity score–matched analysis of adjuvant chemotherapy for stage I non–small cell lung cancer Yasuhiro Tsutani, MD, PhD, Yoshihiro Miyata, MD, PhD,

Commentary: Pursuit of the green jacket: Mastery of the long and short games Daniel P. Raymond, MD The Journal of Thoracic and Cardiovascular Surgery

Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation Michael H. Kwon,

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

Gastric conduit revision after esophagectomy: The raising of Lazarus

Yang Zhang, MD, Haiquan Chen, MD, PhD

Support Your Specialty

Transcatheter aortic valve replacement in intermediate-risk patients

It's not “just a shunt” but sometimes it should be…

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response.

Confusion still exists regarding postoperative delirium and its etiology after esophagectomy Robert B. Cameron, MD The Journal of Thoracic and Cardiovascular.

Stephen R. Broderick, MD, MPHS

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

A fate worse than death Jennifer S. Lawton, MD

Internal validation of risk models in lung resection surgery: Bootstrap versus training- and-test sampling Alessandro Brunelli, MD, Gaetano Rocco, MD

The Ross procedure: Time to reevaluate the guidelines

Manuel J. Antunes, MD, PhD, DSc

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Pathologic complete response after esophagectomy following neoadjuvant chemoradiation therapy for esophageal carcinoma: A cure sometimes? Shawn S. Groth,

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Michael Mack, MD The Journal of Thoracic and Cardiovascular Surgery

The harder one looks, the more one finds

Jason J. Han, MD, Pavan Atluri, MD

Sebastien Gilbert, MD, Andre B. Martel, BSc, Andrew J

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

The continuing challenge of congenital heart disease in China

Bicuspid aortopathy: Seeing the forest for the trees

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

Comparison of surgical techniques for early-stage thymoma: Feasibility of minimally invasive thymectomy and comparison with open resection Arjun Pennathur,

After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10% Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular.

“The more things change…”: The challenges ahead

Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Did you like Terminator 3 better than Terminator 2

How do we follow up our patients

Journal changes and initiatives

Preoperative characteristics and surgical outcomes of acute intramural hematoma involving the ascending aorta: A propensity score–matched analysis Akihito.

Calpain inhibitors: The aspirin of the 21st century?

Kristin A. Higgins, MD, Junzo P. Chino, MD, Neal Ready, MD, Mark W

Presentation transcript:

A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma Haris Zahoor, MD, James D. Luketich, MD, Ryan M. Levy, MD, Omar Awais, DO, Daniel G. Winger, MS, Michael K. Gibson, MD, PhD, Katie S. Nason, MD, MPH The Journal of Thoracic and Cardiovascular Surgery Volume 149, Issue 2, Pages 538-547 (February 2015) DOI: 10.1016/j.jtcvs.2014.10.044 Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 A, Overall survival after minimally invasive esophagectomy (MIE). Propensity-matched comparison of neoadjuvant therapy followed MIE compared with MIE as primary therapy. The numbers in parenthesis are the number of failure events (deaths) between each time point. B, Propensity-matched comparison of the percentage of patients free of recurrence over time after MIE. Neoadjuvant therapy followed by MIE versus MIE as primary therapy. The numbers in parentheses are the number of failure events (deaths) between each time point. In the primary MIE cohort, 1 patient had an R2 resection and persistent disease and was, therefore, never rendered free of disease. Number at risk, therefore, is 96 at time 0. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 538-547DOI: (10.1016/j.jtcvs.2014.10.044) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Survival of propensity-matched groups. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 538-547DOI: (10.1016/j.jtcvs.2014.10.044) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions